Header Logo

Connection

Jean Boucher to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Jean Boucher has written about Clinical Trials, Phase II as Topic.
Jean Boucher
Connection Strength
0.095
Clinical Trials, Phase II as Topic
  1. Boucher J, Olson L, Piperdi B. Preemptive management of dermatologic toxicities associated with epidermal growth factor receptor inhibitors. Clin J Oncol Nurs. 2011 Oct; 15(5):501-8.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.